{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:22:53Z","timestamp":1790803373645,"version":"4.1.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T00:00:00Z","timestamp":1636070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T00:00:00Z","timestamp":1636070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C7923\/A29018"],"award-info":[{"award-number":["C7923\/A29018"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["A18180"],"award-info":[{"award-number":["A18180"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C8640\/A23385"],"award-info":[{"award-number":["C8640\/A23385"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C7923\/A29018"],"award-info":[{"award-number":["C7923\/A29018"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["EDDCPJT\\100018"],"award-info":[{"award-number":["EDDCPJT\\100018"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C7923\/A29018"],"award-info":[{"award-number":["C7923\/A29018"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C18081\/A18180"],"award-info":[{"award-number":["C18081\/A18180"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C8640\/A23385"],"award-info":[{"award-number":["C8640\/A23385"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004622","name":"Dutch Cancer Society","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["50-56300-98-587"],"award-info":[{"award-number":["50-56300-98-587"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"name":"International Alliance for Cancer Early Detection"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2022,3,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Cancer patients often have pre-existing comorbidities, which can influence timeliness of cancer diagnosis. We examined symptoms, investigations and emergency presentation (EP) risk among colorectal cancer (CRC) patients by comorbidity status.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Using linked cancer registration, primary care and hospital records of 4836 CRC patients (2011\u20132015), and multivariate quantile and logistic regression, we examined variations in specialist investigations, diagnostic intervals and EP risk.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Among colon cancer patients, 46% had at least one pre-existing hospital-recorded comorbidity, most frequently cardiovascular disease (CVD, 18%). Comorbid versus non-comorbid cancer patients more frequently had records of anaemia (43% vs 38%), less frequently rectal bleeding\/change in bowel habit (20% vs 27%), and longer intervals from symptom-to-first relevant test (median 136 vs 74 days). Comorbid patients were less likely investigated with colonoscopy\/sigmoidoscopy, independently of symptoms (adjusted OR\u2009=\u20090.7[0.6, 0.9] for Charlson comorbidity score 1\u20132 and OR\u2009=\u20090.5 [0.4\u20130.7] for score 3+ versus 0. EP risk increased with comorbidity score 0, 1, 2, 3+: 23%, 35%, 33%, 47%; adjusted OR\u2009=\u20091.8 [1.4, 2.2]; 1.7 [1.3, 2.3]; 3.0 [2.3, 4.0]) and for patients with CVD (adjusted OR\u2009=\u20092.0 [1.5, 2.5]).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Comorbid individuals with as-yet-undiagnosed CRC often present with general rather than localising symptoms and are less likely promptly investigated with colonoscopy\/sigmoidoscopy. Comorbidity is a risk factor for diagnostic delay and has potential, additionally to symptoms, as risk-stratifier for prioritising patients needing prompt assessment to reduce EP.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1038\/s41416-021-01603-7","type":"journal-article","created":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T07:02:55Z","timestamp":1636095775000},"page":"652-663","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Do presenting symptoms, use of pre-diagnostic endoscopy and risk of emergency cancer diagnosis vary by comorbidity burden and type in patients with colorectal cancer?"],"prefix":"10.1038","volume":"126","author":[{"given":"Sara Benitez","family":"Majano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2873-7421","authenticated-orcid":false,"given":"Georgios","family":"Lyratzopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Rachet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niek J.","family":"de Wit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3845-9493","authenticated-orcid":false,"given":"Cristina","family":"Renzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,5]]},"reference":[{"key":"1603_CR1","unstructured":"UK Government. Department of Health and Social Care. Government announces plans for earlier diagnosis for cancer patients. Available at https:\/\/www.gov.uk\/government\/news\/government-announces-plans-for-earlier-diagnosis-for-cancer-patients (Last accessed March 2020)."},{"key":"1603_CR2","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1136\/flgastro-2017-100926","volume":"9","author":"T Salika","year":"2018","unstructured":"Salika T, Abel GA, Mendonca SC, von Wagner C, Renzi C, Herbert A, et al. Associations between diagnostic pathways and care experience in colorectal cancer: evidence from patient-reported data. Frontline Gastroenterol. 2018;9:241\u20138.","journal-title":"Frontline Gastroenterol."},{"key":"1603_CR3","unstructured":"NCIN. Routes to diagnosis 2006\u20132016 workbook. PHE. Available at http:\/\/www.ncin.org.uk\/publications\/routes_to_diagnosis (Last accessed June 2020)."},{"key":"1603_CR4","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/nrclinonc.2016.109","volume":"13","author":"W Hamilton","year":"2016","unstructured":"Hamilton W, Walter FM, Rubin G, Neal RD. Improving early diagnosis of symptomatic cancer. Nat Rev Clin Oncol. 2016;13:740.","journal-title":"Nat Rev Clin Oncol."},{"key":"1603_CR5","doi-asserted-by":"publisher","first-page":"e000293","DOI":"10.1136\/bmjgast-2019-000293","volume":"6","author":"C Mowat","year":"2019","unstructured":"Mowat C, Digby J, Strachan JA, McCann R, Hall C, Heather D, et al. Impact of introducing a faecal immunochemical test (FIT) for haemoglobin into primary care on the outcome of patients with new bowel symptoms: a prospective cohort study. BMJ Open Gastroenterol. 2019;6:e000293.","journal-title":"BMJ Open Gastroenterol"},{"key":"1603_CR6","doi-asserted-by":"crossref","unstructured":"Nicholson BD, James T, Paddon M, Justice S, Oke JL, East JE, et al. Faecal immunochemical testing for adults with symptoms of colorectal cancer attending English primary care: a retrospective cohort study of 14 487 consecutive test requests. Aliment Pharmacol Ther. 2020;52:1031\u201341.","DOI":"10.1111\/apt.15969"},{"key":"1603_CR7","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nrclinonc.2016.155","volume":"14","author":"Y Zhou","year":"2017","unstructured":"Zhou Y, Abel GA, Hamilton W, Pritchard-Jones K, Gross CP, Walter FM, et al. Diagnosis of cancer as an emergency: a critical review of current evidence. Nat Rev Clin Oncol. 2017;14:45\u201356.","journal-title":"Nat Rev Clin Oncol."},{"key":"1603_CR8","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1136\/gut.2007.120253","volume":"57","author":"SJ Goodyear","year":"2008","unstructured":"Goodyear SJ, Leung E, Menon A, Pedamallu S, Williams N, Wong LS. The effects of population-based faecal occult blood test screening upon emergency colorectal cancer admissions in Coventry and north Warwickshire. Gut. 2008;57:218\u201322.","journal-title":"Gut."},{"key":"1603_CR9","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.canep.2019.04.011","volume":"61","author":"TM Pham","year":"2019","unstructured":"Pham TM, Gomez-Cano M, Salika T, Jardel D, Abel GA, Lyratzopoulos G. Diagnostic route is associated with care satisfaction independently of tumour stage: Evidence from linked English Cancer Patient Experience Survey and cancer registration data. Cancer Epidemiol. 2019;61:70\u20138.","journal-title":"Cancer Epidemiol"},{"key":"1603_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4274-0","volume":"18","author":"M Laudicella","year":"2018","unstructured":"Laudicella M, Walsh B, Burns E, Li Donni P, Smith PC. What is the impact of rerouting a cancer diagnosis from emergency presentation to GP referral on resource use and survival? Evidence from a population-based study. BMC Cancer. 2018;18:394.","journal-title":"BMC Cancer."},{"key":"1603_CR11","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/s41571-019-0249-6","volume":"16","author":"C Renzi","year":"2019","unstructured":"Renzi C, Kaushal A, Emery J, Hamilton W, Neal RD, Rachet B, et al. Comorbid chronic diseases and cancer diagnosis: disease-specific effects and underlying mechanisms. Nat Rev Clin Oncol. 2019;16:746\u201361.","journal-title":"Nat Rev Clin Oncol."},{"key":"1603_CR12","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.canep.2019.05.010","volume":"61","author":"C Pearson","year":"2019","unstructured":"Pearson C, Fraser J, Peake M, Valori R, Poirier V, Coupland VH, et al. Establishing population-based surveillance of diagnostic timeliness using linked cancer registry and administrative data for patients with colorectal and lung cancer. Cancer Epidemiol. 2019;61:111\u20138.","journal-title":"Cancer Epidemiol"},{"key":"1603_CR13","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1038\/bjc.2017.127","volume":"116","author":"LTA Mounce","year":"2017","unstructured":"Mounce LTA, Price S, Valderas JM, Hamilton W. Comorbid conditions delay diagnosis of colorectal cancer: a cohort study using electronic primary care records. Br J Cancer. 2017;116:1536\u201343.","journal-title":"Br J Cancer."},{"key":"1603_CR14","doi-asserted-by":"publisher","first-page":"e63","DOI":"10.3399\/bjgp17X694169","volume":"68","author":"R Swann","year":"2018","unstructured":"Swann R, McPhail S, Witt J, Shand B, Abel GA, Hiom S, et al. Diagnosing cancer in primary care: results from the National Cancer Diagnosis Audit. Br J Gen Pract. 2018;68:e63\u2013e72.","journal-title":"Br J Gen Pract."},{"key":"1603_CR15","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.1002\/cncr.30801","volume":"123","author":"CS Ritchie","year":"2017","unstructured":"Ritchie CS, Zhao F, Patel K, Manola J, Kvale EA, Snyder CF, et al. Association between patients\u2019 perception of the comorbidity burden and symptoms in outpatients with common solid tumors. Cancer. 2017;123:3835\u201342.","journal-title":"Cancer."},{"key":"1603_CR16","doi-asserted-by":"publisher","first-page":"e245","DOI":"10.3399\/bjgp18X695465","volume":"68","author":"A Cassell","year":"2018","unstructured":"Cassell A, Edwards D, Harshfield A, Rhodes K, Brimicombe J, Payne R, et al. The epidemiology of multimorbidity in primary care: a retrospective cohort study. Br J Gen Pract. 2018;68:e245\u2013e51.","journal-title":"Br J Gen Pract."},{"key":"1603_CR17","doi-asserted-by":"publisher","first-page":"e598","DOI":"10.3399\/bjgp20X712193","volume":"70","author":"C Renzi","year":"2020","unstructured":"Renzi C, Lyratzopoulos G. Comorbidity and the diagnosis of symptomatic-but-as-yet-undiagnosed cancer. Br J Gen Pract. 2020;70:e598\u2013e9.","journal-title":"Br J Gen Pract."},{"key":"1603_CR18","doi-asserted-by":"crossref","unstructured":"Maringe C, Spicer J, Morris M, Purushotham A, Nolte E, Sullivan R, et al. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study. Lancet Oncol. 2020;21:1023\u201334.","DOI":"10.1016\/S1470-2045(20)30388-0"},{"key":"1603_CR19","doi-asserted-by":"crossref","unstructured":"Sud A, Jones M, Broggio J, Loveday C, Torr B, Garrett A, et al. Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic. Ann Oncol. 2020.31:1065\u201374.","DOI":"10.1016\/j.annonc.2020.05.009"},{"key":"1603_CR20","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/S1470-2045(20)30242-4","volume":"21","author":"D Jones","year":"2020","unstructured":"Jones D, Neal RD, Duffy SRG, Scott SE, Whitaker KL, Brain K. Impact of the COVID-19 pandemic on the symptomatic diagnosis of cancer: the view from primary care. Lancet Oncol. 2020;21:748\u201350.","journal-title":"Lancet Oncol."},{"key":"1603_CR21","doi-asserted-by":"publisher","first-page":"e13265","DOI":"10.1111\/ecc.13265","volume":"29","author":"D Weller","year":"2020","unstructured":"Weller D. Cancer diagnosis and treatment in the COVID-19 era. Eur J Cancer Care (Engl). 2020;29:e13265.","journal-title":"Eur J Cancer Care (Engl)."},{"key":"1603_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-019-4075-4","volume":"19","author":"C Renzi","year":"2019","unstructured":"Renzi C, Lyratzopoulos G, Hamilton W, Maringe C, Rachet B. Contrasting effects of comorbidities on emergency colon cancer diagnosis: a longitudinal data-linkage study in England. BMC health Serv Res. 2019;19:311.","journal-title":"BMC health Serv Res."},{"key":"1603_CR23","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1038\/bjc.2012.408","volume":"107","author":"L Elliss-Brookes","year":"2012","unstructured":"Elliss-Brookes L, McPhail S, Ives A, Greenslade M, Shelton J, Hiom S, et al. Routes to diagnosis for cancer \u2014 determining the patient journey using multiple routine data sets. Br J Cancer. 2012;107:1220\u20136.","journal-title":"Br J Cancer."},{"key":"1603_CR24","unstructured":"Cancer Research UK. Routes to diagnosis of bowel cancer. Available at https:\/\/www.cancerresearchuk.org\/health-professional\/bowel-cancer-screening-and-diagnosis-statistics#ref-1 (Last accessed June 2021)."},{"key":"1603_CR25","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ije\/dyz076","volume":"49","author":"KE Henson","year":"2020","unstructured":"Henson KE, Elliss-Brookes L, Coupland VH, Payne E, Vernon S, Rous B, et al. Data resource profile: National Cancer Registration Dataset in England. Int J Epidemiol 2020;49:16\u201316h.","journal-title":"Int J Epidemiol"},{"key":"1603_CR26","unstructured":"CPRD. CPRD linked data. Available at https:\/\/cprd.com\/linked-data (Last accessed April 2020)."},{"key":"1603_CR27","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/ije\/dyv098","volume":"44","author":"E Herrett","year":"2015","unstructured":"Herrett E, Gallagher AM, Bhaskaran K, Forbes H, Mathur R, van Staa T, et al. Data Resource Profile: Clinical Practice Research Datalink (CPRD). Int J Epidemiol. 2015;44:827\u201336.","journal-title":"Int J Epidemiol."},{"key":"1603_CR28","doi-asserted-by":"crossref","unstructured":"Padmanabhan S, Carty L, Cameron E, Ghosh RE, Williams R, Strongman H. Approach to record linkage of primary care data from Clinical Practice Research Datalink to other health-related patient data: overview and implications. Eur J Epidemiol. 2018;34:91\u20139.","DOI":"10.1007\/s10654-018-0442-4"},{"key":"1603_CR29","doi-asserted-by":"publisher","first-page":"e0172814","DOI":"10.1371\/journal.pone.0172814","volume":"12","author":"C Maringe","year":"2017","unstructured":"Maringe C, Fowler H, Rachet B, Luque-Fernandez MA. Reproducibility, reliability and validity of population-based administrative health data for the assessment of cancer non-related comorbidities. PLoS ONE. 2017;12:e0172814.","journal-title":"PLoS ONE."},{"key":"1603_CR30","doi-asserted-by":"publisher","first-page":"e0127717","DOI":"10.1371\/journal.pone.0127717","volume":"10","author":"NU Din","year":"2015","unstructured":"Din NU, Ukoumunne OC, Rubin G, Hamilton W, Carter B, Stapley S, et al. Age and Gender Variations in Cancer Diagnostic Intervals in 15 Cancers: Analysis of Data from the UK Clinical Practice Research Datalink. PLoS ONE. 2015;10:e0127717.","journal-title":"PLoS ONE."},{"key":"1603_CR31","unstructured":"NICE guidelines [NG12]. Suspected cancer: recognition and referral. Available at http:\/\/www.nice.org.uk\/guidance\/NG12\/chapter\/1-Recommendations-organised-by-site-of-cancer (Last accessed May 2020)."},{"key":"1603_CR32","first-page":"l6090","volume":"367","author":"NE Burr","year":"2019","unstructured":"Burr NE, Derbyshire E, Taylor J, Whalley S, Subramanian V, Finan PJ, et al. Variation in post-colonoscopy colorectal cancer across colonoscopy providers in English National Health Service: population based cohort study. BMJ (Clin Res ed). 2019;367:l6090.","journal-title":"BMJ (Clin Res ed)."},{"key":"1603_CR33","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1093\/pubmed\/fdr054","volume":"34","author":"EM Burns","year":"2012","unstructured":"Burns EM, Rigby E, Mamidanna R, Bottle A, Aylin P, Ziprin P, et al. Systematic review of discharge coding accuracy. J Public Health. 2012;34:138\u201348.","journal-title":"J Public Health."},{"key":"1603_CR34","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.canep.2017.04.010","volume":"48","author":"MM Koo","year":"2017","unstructured":"Koo MM, von Wagner C, Abel GA, McPhail S, Rubin GP, Lyratzopoulos G. Typical and atypical presenting symptoms of breast cancer and their associations with diagnostic intervals: evidence from a national audit of cancer diagnosis. Cancer Epidemiol. 2017;48:140\u20136.","journal-title":"Cancer Epidemiol"},{"key":"1603_CR35","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S2352-4642(18)30004-X","volume":"2","author":"A Herbert","year":"2018","unstructured":"Herbert A, Lyratzopoulos G, Whelan J, Taylor RM, Barber J, Gibson F, et al. Diagnostic timeliness in adolescents and young adults with cancer: a cross-sectional analysis of the BRIGHTLIGHT cohort. Lancet Child Adolesc Health. 2018;2:180\u201390.","journal-title":"Lancet Child Adolesc Health."},{"key":"1603_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-015-1317-7","volume":"15","author":"H Jensen","year":"2015","unstructured":"Jensen H, Torring ML, Olesen F, Overgaard J, Fenger-Gron M, Vedsted P. Diagnostic intervals before and after implementation of cancer patient pathways - a GP survey and registry based comparison of three cohorts of cancer patients. BMC Cancer. 2015;15:308.","journal-title":"BMC Cancer."},{"key":"1603_CR37","doi-asserted-by":"publisher","first-page":"e023870","DOI":"10.1136\/bmjopen-2018-023870","volume":"8","author":"D Weller","year":"2018","unstructured":"Weller D, Menon U, Zalounina Falborg A, Jensen H, Barisic A, Knudsen AK, et al. Diagnostic routes and time intervals for patients with colorectal cancer in 10 international jurisdictions; findings from a cross-sectional study from the International Cancer Benchmarking Partnership (ICBP). BMJ Open. 2018;8:e023870.","journal-title":"BMJ Open."},{"key":"1603_CR38","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1136\/gutjnl-2012-304202","volume":"63","author":"M Shawihdi","year":"2014","unstructured":"Shawihdi M, Thompson E, Kapoor N, Powell G, Sturgess RP, Stern N, et al. Variation in gastroscopy rate in English general practice and outcome for oesophagogastric cancer: retrospective analysis of Hospital Episode Statistics. Gut. 2014;63:250\u201361.","journal-title":"Gut."},{"key":"1603_CR39","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1136\/bmjqs-2017-006607","volume":"27","author":"G Abel","year":"2018","unstructured":"Abel G, Saunders CL, Mendonca SC, Gildea C, McPhail S, Lyratzopoulos G. Variation and statistical reliability of publicly reported primary care diagnostic activity indicators for cancer: a cross-sectional ecological study of routine data. BMJ Qual Saf. 2018;27:21\u201330.","journal-title":"BMJ Qual Saf"},{"key":"1603_CR40","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1093\/fampra\/cmy118","volume":"36","author":"SC Mendonca","year":"2019","unstructured":"Mendonca SC, Abel GA, Gildea C, McPhail S, Peake MD, Rubin G, et al. Associations between general practice characteristics with use of urgent referrals for suspected cancer and endoscopies: a cross-sectional ecological study. Fam Pract. 2019;36:573\u201380.","journal-title":"Fam Pract."},{"key":"1603_CR41","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/EDE.0000000000000554","volume":"28","author":"EF Schisterman","year":"2017","unstructured":"Schisterman EF, Perkins NJ, Mumford SL, Ahrens KA, Mitchell EM. Collinearity and causal diagrams: a lesson on the Importance of model specification. Epidemiol (Camb, Mass). 2017;28:47\u201353.","journal-title":"Epidemiol (Camb, Mass)."},{"key":"1603_CR42","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/bjc.2016.250","volume":"115","author":"C Renzi","year":"2016","unstructured":"Renzi C, Lyratzopoulos G, Card T, Chu TP, Macleod U, Rachet B. Do colorectal cancer patients diagnosed as an emergency differ from non-emergency patients in their consultation patterns and symptoms? A longitudinal data-linkage study in England. Br J Cancer. 2016;115:866\u201375.","journal-title":"Br J Cancer"},{"key":"1603_CR43","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1038\/ajg.2009.324","volume":"104","author":"H Singh","year":"2009","unstructured":"Singh H, Daci K, Petersen LA, Collins C, Petersen NJ, Shethia A, et al. Missed opportunities to initiate endoscopic evaluation for colorectal cancer diagnosis. Am J Gastroenterol. 2009;104:2543\u201354.","journal-title":"Am J Gastroenterol"},{"key":"1603_CR44","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1370\/afm.2446","volume":"17","author":"NF van Erp","year":"2019","unstructured":"van Erp NF, Helsper CW, Olyhoek SM, Janssen RRT, Winsveen A, Peeters PHM, et al. Potential for reducing time to referral for colorectal cancer patients in primary care. Ann Fam Med. 2019;17:419\u201327.","journal-title":"Ann Fam Med"},{"key":"1603_CR45","doi-asserted-by":"publisher","first-page":"e463","DOI":"10.3399\/bjgp20X710441","volume":"70","author":"CS Arhi","year":"2020","unstructured":"Arhi CS, Burns EM, Bottle A, Bouras G, Aylin P, Ziprin P, et al. Delays in referral from primary care worsen survival for patients with colorectal cancer: a retrospective cohort study. Br J Gen Pract. 2020;70:e463\u2013e71.","journal-title":"Br J Gen Pract."},{"key":"1603_CR46","doi-asserted-by":"crossref","unstructured":"Abel G, Shelton J, Johnson S, Elliss-Brookes L, Lyratzopoulos G. Cancer-specific variation in emergency presentation by sex, age and deprivation across 27 common and rarer cancers. Br J Cancer. 2015.;112:S129\u201336.","DOI":"10.1038\/bjc.2015.52"},{"key":"1603_CR47","doi-asserted-by":"publisher","first-page":"e006965","DOI":"10.1136\/bmjopen-2014-006965","volume":"5","author":"E Mitchell","year":"2015","unstructured":"Mitchell E, Pickwell-Smith B, Macleod U. Risk factors for emergency presentation with lung and colorectal cancers: a systematic review. BMJ Open. 2015;5:e006965.","journal-title":"BMJ Open."},{"key":"1603_CR48","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/bjc.2016.221","volume":"115","author":"FM Walter","year":"2016","unstructured":"Walter FM, Emery JD, Mendonca S, Hall N, Morris HC, Mills K, et al. Symptoms and patient factors associated with longer time to diagnosis for colorectal cancer: results from a prospective cohort study. Br J Cancer. 2016;115:533\u201341.","journal-title":"Br J Cancer."},{"key":"1603_CR49","unstructured":"Cancer Data. Available at https:\/\/cancerdata.nhs.uk\/secondary_care_diagnostic_intervals\/all_routes (Last accessed July 2020)."},{"key":"1603_CR50","doi-asserted-by":"publisher","first-page":"S92","DOI":"10.1038\/bjc.2015.48","volume":"112","author":"RD Neal","year":"2015","unstructured":"Neal RD, Tharmanathan P, France B, Din NU, Cotton S, Fallon-Ferguson J, et al. Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review. Br J Cancer. 2015;112:S92\u2013107.","journal-title":"Br J Cancer."},{"key":"1603_CR51","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1038\/bjc.2017.236","volume":"117","author":"ML T\u00f8rring","year":"2017","unstructured":"T\u00f8rring ML, Murchie P, Hamilton W, Vedsted P, Esteva M, Lautrup M, et al. Evidence of advanced stage colorectal cancer with longer diagnostic intervals: a pooled analysis of seven primary care cohorts comprising 11\u2009720 patients in five countries. Br J Cancer. 2017;117:888\u201397.","journal-title":"Br J Cancer."},{"key":"1603_CR52","doi-asserted-by":"publisher","first-page":"E107","DOI":"10.1503\/cmaj.190757","volume":"192","author":"RA Payne","year":"2020","unstructured":"Payne RA, Mendonca SC, Elliott MN, Saunders CL, Edwards DA, Marshall M, et al. Development and validation of the Cambridge Multimorbidity Score. CMAJ 2020;192:E107\u2013e14.","journal-title":"CMAJ"},{"key":"1603_CR53","doi-asserted-by":"publisher","first-page":"101845","DOI":"10.1016\/j.canep.2020.101845","volume":"69","author":"MM Koo","year":"2020","unstructured":"Koo MM, Swann R, McPhail S, Abel GA, Renzi C, Rubin GP, et al. The prevalence of chronic conditions in patients diagnosed with one of 29 common and rarer cancers: a cross-sectional study using primary care data. Cancer Epidemiol. 2020;69:101845.","journal-title":"Cancer Epidemiol."},{"key":"1603_CR54","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1097\/MEG.0b013e32834c4839","volume":"23","author":"AM Van Hout","year":"2011","unstructured":"Van Hout AM, de Wit NJ, Rutten FH, Peeters PH. Determinants of patient\u2019s and doctor\u2019s delay in diagnosis and treatment of colorectal cancer. Eur J Gastroenterol Hepatol. 2011;23:1056\u201363.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1603_CR55","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1038\/bjc.2013.569","volume":"109","author":"S McPhail","year":"2013","unstructured":"McPhail S, Elliss-Brookes L, Shelton J, Ives A, Greenslade M, Vernon S, et al. Emergency presentation of cancer and short-term mortality. Br J Cancer. 2013;109:2027\u201334.","journal-title":"Br J Cancer."},{"key":"1603_CR56","doi-asserted-by":"publisher","first-page":"k764","DOI":"10.1136\/bmj.k764","volume":"360","author":"A Exarchakou","year":"2018","unstructured":"Exarchakou A, Rachet B, Belot A, Maringe C, Coleman MP. Impact of national cancer policies on cancer survival trends and socioeconomic inequalities in England, 1996-2013: population based study. BMJ (Clin Res ed). 2018;360:k764.","journal-title":"BMJ (Clin Res ed)."},{"key":"1603_CR57","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1038\/bjc.2017.295","volume":"117","author":"H Fowler","year":"2017","unstructured":"Fowler H, Belot A, Njagi EN, Luque-Fernandez MA, Maringe C, Quaresma M, et al. Persistent inequalities in 90-day colon cancer mortality: an English cohort study. Br J Cancer. 2017;117:1396\u2013404.","journal-title":"Br J Cancer."},{"key":"1603_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-016-0684-5","volume":"14","author":"SG Elias","year":"2016","unstructured":"Elias SG, Kok L, de Wit NJ, Witteman BJ, Goedhard JG, Romberg-Camps MJ, et al. Is there an added value of faecal calprotectin and haemoglobin in the diagnostic work-up for primary care patients suspected of significant colorectal disease? A cross-sectional diagnostic study. BMC Med. 2016;14:141.","journal-title":"BMC Med."},{"key":"1603_CR59","doi-asserted-by":"crossref","unstructured":"D\u2019Souza N, Georgiou Delisle T, Chen M, Benton S, Abulafi M. Faecal immunochemical test is superior to symptoms in predicting pathology in patients with suspected colorectal cancer symptoms referred on a 2WW pathway: a diagnostic accuracy study. Gut. 2020;70:1130\u201338.","DOI":"10.1136\/gutjnl-2020-321956"},{"key":"1603_CR60","doi-asserted-by":"publisher","first-page":"e043828","DOI":"10.1136\/bmjopen-2020-043828","volume":"10","author":"AG Lai","year":"2020","unstructured":"Lai AG, Pasea L, Banerjee A, Hall G, Denaxas S, Chang WH, et al. Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer deaths and a population-based cohort study. BMJ Open. 2020;10:e043828.","journal-title":"BMJ Open."},{"key":"1603_CR61","doi-asserted-by":"crossref","unstructured":"Renzi C, Whitaker KL, Wardle J. Over-reassurance and undersupport after a \u2018false alarm\u2019: a systematic review of the impact on subsequent cancer symptom attribution and help seeking. BMJ Open. 2015;5:e007002.","DOI":"10.1136\/bmjopen-2014-007002"},{"key":"1603_CR62","doi-asserted-by":"publisher","first-page":"S50","DOI":"10.1038\/bjc.2015.42","volume":"112","author":"E Mitchell","year":"2015","unstructured":"Mitchell E, Rubin G, Merriman L, Macleod U. The role of primary care in cancer diagnosis via emergency presentation: qualitative synthesis of significant event reports. Br J Cancer. 2015;112:S50\u20136.","journal-title":"Br J Cancer."},{"key":"1603_CR63","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1093\/fampra\/cmv048","volume":"32","author":"S McLachlan","year":"2015","unstructured":"McLachlan S, Mansell G, Sanders T, Yardley S, van der Windt D, Brindle L, et al. Symptom perceptions and help-seeking behaviour prior to lung and colorectal cancer diagnoses: a qualitative study. Fam Pract. 2015;32:568\u201377.","journal-title":"Fam Pract."},{"key":"1603_CR64","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.canep.2018.03.011","volume":"54","author":"A Foster","year":"2018","unstructured":"Foster A, Renzi C, Lyratzopoulos G. Diagnosing cancer in patients with \u2018non-alarm\u2019 symptoms: Learning from diagnostic care innovations in Denmark. Cancer Epidemiol. 2018;54:101\u20133.","journal-title":"Cancer Epidemiol."},{"key":"1603_CR65","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/s41416-020-0947-y","volume":"123","author":"D Chapman","year":"2020","unstructured":"Chapman D, Poirier V, Vulkan D, Fitzgerald K, Rubin G, Hamilton W, et al. First results from five multidisciplinary diagnostic centre (MDC) projects for non-specific but concerning symptoms, possibly indicative of cancer. Br J Cancer. 2020;123:722\u20139.","journal-title":"Br J Cancer."},{"key":"1603_CR66","unstructured":"NCIN. Routes to Diagnosis: Exploring Emergency Presentations. Public Health England; 2013."}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-021-01603-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-021-01603-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-021-01603-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T12:27:28Z","timestamp":1675859248000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-021-01603-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,5]]},"references-count":66,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,3,9]]}},"alternative-id":["1603"],"URL":"https:\/\/doi.org\/10.1038\/s41416-021-01603-7","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,5]]},"assertion":[{"value":"19 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the MHRA (UK) Independent Scientific Advisory Committee (ISAC-Protocol 18_299RMnA5), under Section 251 (NHS Social Care Act 2006). This study is based in part on data from the Clinical Practice Research Datalink obtained under licence from the UK Medicines and Healthcare products Regulatory Agency. The data are provided by patients and collected by the NHS as part of their care and support. The interpretation and conclusions contained in this study are those of the authors alone. The study was performed in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}